Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial
Article in Nature Communications (March 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)
Article in Journal for ImmunoTherapy of Cancer (September 2022)
The Role of Peptide-Based Tumor Vaccines on Cytokines of Adaptive Immunity: A Review
Article in International Journal of Peptide Research and Therapeutics (August 2021)